Fluotsynolona atsetonyd | Flucinar gel 0.025%, 15 g

Latin name

FLUCINAR

Release form

Gel for external use.

Indications

Severe inflammatory and allergic diseases of the skin and mucous membranes (including those resistant to therapy with other corticosteroids): neurodermatitis, eczema, psoriasis, lichen planus, seborrheic dermatitis.

Contraindications

Hypersensitivity

acne

bacterial (including tuberculosis), fungal, viral and tumor skin diseases.

Use during pregnancy and lactation

Not recommended during pregnancy.

Composition of

1 g of gel contains:

Active ingredient: fluocinolone acetonide 0.25 mg

Excipients: propylene glycol ethanol disodium salt of ethylenediaminetetraacetic acid (trilon B) acid citric methylhydroxybenzenesulfonate 9-hydroxybenzenesulfonate 9.

Dosage and Administration

Externally. Apply to the affected surface, rubbing lightly, 1-2 times a day, not more than 2 g / day. With psoriasis, an occlusive dressing is possible. Course duration - no more than 1-2 weeks. Apply very carefully on the skin of the face and not more than 1 week.

Children over 2 years of age - with caution, only 1 time per day, on small areas of the skin.

Side effects

Atrophy of the skin and subcutaneous adipose tissue, lupus-like syndrome with mild course, onset or worsening of symptoms of lichen planus, epithelialization disorders, delayed healing of wounds and ulcerative lesions, petechiae, steroid purpura, striae, miriapus skin rash.

Overdose

Symptoms: if the dosage regimen is not followed (prolonged use of the drug on large areas of the skin), systemic side effects of the drug, such as increased blood pressure, edema, immunosuppressive effect.

Treatment: drug withdrawal.

Storage Conditions

At a temperature not exceeding 25 РC. Do not freeze.

Term hodnosty

3 years

active substance

fluocinolone acetonide

Pharmacy terms

Without a prescription

Dosage form

gel for external use

Elf Farmzavod, Poland